Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
The first FDA-cleared device that supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our five FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without additional equipment, procedures or radiation dose.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
Riverain Technologies is happy to announce that Jonathan Chung, MD, has accepted a clinical advisor position. Dr. Chung, Professor of Radiology; Chief of Cardiothoracic Imaging, and Chief Quality Officer in Radiology at the University of Chicago Medicine, specializes in cardiopulmonary imaging. He has authored over 140 peer-reviewed articles that have been published in scientific journals, co-authored five book chapters and five books that focus on chest diagnostics. He has practiced Radiology since 2010.
“We are extremely pleased to welcome Dr. Chung to Riverain’s clinical advisory board to help drive our leading solutions in thoracic radiology. Dr. Chung’s depth and breadth of knowledge will be a tremendous asset for Riverain going forward,” stated Steve Worrell, CEO.
Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
